Bone Marrow Edema Management in Orthopedic Conditions

Bone marrow edema (BME) is characterised by increased interstitial fluid within the trabecular bone and manifests clinically as pain, reduced mobility and, on magnetic resonance imaging (MRI), high-signal intensity on fluid-sensitive sequences. In orthopedic practice, BME arises in diverse settings, including transient osteoporosis, osteoarthritis, stress injuries and avascular necrosis. Pathophysiological mechanisms encompass venous stasis, intraosseous hypertension and local ischaemia, which drive pain and structural bone remodelling. Management strategies range from conservative measures—activity modification, analgesia and weight-bearing restrictions—to pharmacological interventions with bisphosphonates or vasoactive agents and non-invasive modalities such as extracorporeal shock wave therapy. In refractory or severe cases, surgical core decompression or fenestration restores perfusion, relieves intraosseous pressure and promotes resolution of oedema. Current practice emphasises individualised treatment algorithms guided by clinical severity, imaging findings and underlying aetiology, with a growing evidence base supporting both established and novel therapeutics.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Bone Marrow Edema Management in Orthopedic Conditions publication trend

The graph below shows the total number of articles in bone marrow edema management in orthopedic conditions across all publications each year (not limited to Nature Index journals).

Technical terms

Bone marrow edema (BME): Accumulation of excess fluid within trabecular bone, visible on MRI as areas of high signal intensity on fluid-sensitive sequences.

Magnetic resonance imaging (MRI): A non-invasive imaging modality that uses magnetic fields and radiofrequency pulses to produce detailed internal tissue contrast, essential for detecting BME.

Bisphosphonates: A class of antiresorptive drugs that inhibit osteoclast-mediated bone breakdown and are used to stabilise bone metabolism in conditions such as osteoporosis and BME.

Extracorporeal shock wave therapy (ESWT): A non-invasive treatment delivering focused acoustic waves to bone tissue, promoting neovascularisation and stimulating tissue regeneration.

Core decompression: A surgical technique that drills or fenestrates the affected bone to relieve intraosseous pressure and restore blood flow, used in refractory BME and early avascular necrosis.

References

1. Spontaneous Bone Marrow Edema: Perfusion Abnormalities and Treatment with Surgical Decompression. International Journal of Molecular Sciences (2023).
2. Efficacy of Zoledronic Acid in the Treatment of Nonmalignant Painful Bone Marrow Lesions: A Triple‐Blind, Randomized, Placebo‐Controlled Phase III Clinical Trial (ZoMARS). Journal of Bone and Mineral Research (2020).
3. How We Manage Bone Marrow Edema—An Interdisciplinary Approach. Journal of Clinical Medicine (2020).
4. The use of extracorporeal shock wave therapy for the treatment of bone marrow oedema — a systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research (2021).